These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3569543)

  • 21. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog.
    Engler R; Covell JW
    Circ Res; 1987 Jul; 61(1):20-8. PubMed ID: 3038366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
    Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "no-reflow" phenomenon after temporary coronary occlusion in the dog.
    Kloner RA; Ganote CE; Jennings RB
    J Clin Invest; 1974 Dec; 54(6):1496-508. PubMed ID: 4140198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No-reflow phenomenon and acute myocardial ischemia. The need for further investigation.
    Camilleri JP; Fabiani JN
    Biomedicine; 1977 Dec; 26(6):353-6. PubMed ID: 606301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation.
    Schmid-Schönbein GW
    Fed Proc; 1987 May; 46(7):2397-401. PubMed ID: 3552737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusion.
    Engler RL
    Am J Cardiol; 1989 Mar; 63(10):19E-23E. PubMed ID: 2538048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the coronary microcirculation in myocardial recovery from ischemia.
    McDonagh PF
    Yale J Biol Med; 1983; 56(4):303-11. PubMed ID: 6422651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of adenosine in myocardial ischemia.
    Ely SW; Berne RM
    Circulation; 1992 Mar; 85(3):893-904. PubMed ID: 1537125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of collateral blood circulation on the liberation of lysosomal hydrolases in acute ischemia of the myocardium].
    Gottwik MG; Kirk ES; Weglicki WB
    Verh Dtsch Ges Kreislaufforsch; 1975; 41():140-3. PubMed ID: 1241824
    [No Abstract]   [Full Text] [Related]  

  • 30. Perspectives of leukocyte activation in the microcirculation.
    Schmid-Schönbein GW; Engler RL
    Biorheology; 1990; 27(6):859-69. PubMed ID: 2093394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte activation and capillary obstruction.
    Schmid-Schönbein GW
    Monogr Atheroscler; 1990; 15():150-9. PubMed ID: 2404193
    [No Abstract]   [Full Text] [Related]  

  • 32. Ischemia at the crossroads?
    Hearse DJ
    Cardiovasc Drugs Ther; 1988 May; 2(1):9-15. PubMed ID: 3154700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine. The signal of life?
    Engler RL
    Circulation; 1991 Aug; 84(2):951-4. PubMed ID: 1860244
    [No Abstract]   [Full Text] [Related]  

  • 34. Adenosine revisited.
    Lancet; 1985 Oct; 2(8461):927-8. PubMed ID: 2865425
    [No Abstract]   [Full Text] [Related]  

  • 35. Adenosine kinase: A key regulator of purinergic physiology.
    Boison D; Jarvis MF
    Biochem Pharmacol; 2021 May; 187():114321. PubMed ID: 33161022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of adenosine kinase inhibition-Revisited.
    Jarvis MF
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00506. PubMed ID: 31367385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model.
    van der Pals J; Koul S; Andersson P; Götberg M; Ubachs JF; Kanski M; Arheden H; Olivecrona GK; Larsson B; Erlinge D
    BMC Cardiovasc Disord; 2010 Sep; 10():45. PubMed ID: 20875134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of neutrophil activity improves cardiac function after cardiopulmonary bypass.
    Abdel-Rahman U; Margraf S; Aybek T; Lögters T; Bitu-Moreno J; Francischetti I; Kranert T; Grünwald F; Windolf J; Moritz A; Scholz M
    J Inflamm (Lond); 2007 Oct; 4():21. PubMed ID: 17925040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.
    Di Paola R; Cuzzocrea S
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):157-75. PubMed ID: 17394034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential.
    McGaraughty S; Cowart M; Jarvis MF
    CNS Drug Rev; 2001; 7(4):415-32. PubMed ID: 11830758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.